Rakuten Securities’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.27K | Sell |
26
-17
| -40% | -$2.14K | ﹤0.01% | 545 |
|
|
2025
Q1 | $4.76K | Buy |
43
+12
| +39% | +$1.33K | ﹤0.01% | 498 |
|
|
2024
Q4 | $4.23K | Buy |
31
+30
| +3,000% | +$4.1K | ﹤0.01% | 502 |
|
|
2024
Q3 | $115 | Sell |
1
-1
| -50% | -$115 | ﹤0.01% | 683 |
|
|
2024
Q2 | $275 | Sell |
2
-23
| -92% | -$3.16K | ﹤0.01% | 638 |
|
|
2024
Q1 | $3.45K | Sell |
25
-3
| -11% | -$414 | ﹤0.01% | 438 |
|
|
2023
Q4 | $3.69K | Buy |
+28
| New | +$3.69K | ﹤0.01% | 380 |
|